Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Plos One|May 10, 2012
Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasionEdmund Kwok-Kwan Tung, Betty Yin-Chi Wong, Tai-On Yau, et al.
Developmental Biology|December 17, 2002
Auto/cross-regulation of Hoxb3 expression in posterior hindbrain and spinal cordTai On Yau, Chung Tin Kwan, L Martin Jakt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinomaChun-Fung Chan, Tai-On Yau, Dong-Yan Jin, et al.
International Journal of Cancer|December 25, 2008
HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functionsEdmund Kwok-Kwan Tung, Chun-Ming Wong, Tai-On Yau, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 16, 2005
Hoxb3 vagal neural crest-specific enhancer element for controlling enteric nervous system developmentKwok Keung Chan, Yuk Shan Chen, Tai On Yau, et al.
Oncogene|December 8, 2004
HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencingTai-On Yau, Chung-Yiu Chan, Kok-Lung Chan, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significanceKaren Man-Fong Sze, Kris Lai-Ting Wong, Glanice Kin-Yan Chu, et al.
Cancer Research|October 6, 2005
Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinomaChun-Ming Wong, Judy Wai-Ping Yam, Yick-Pang Ching, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2005
Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activityThomas Ho-Yin Leung, Yick-Pang Ching, Judy Wai Ping Yam, et al.
Cancer Research|March 10, 2011
Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasisGrace Wing-Yan Mak, Mandy Man-Lok Chan, Veronica Yee-Law Leong, et al.
Pageof 2